
Inhaler spacer Visiomed
SKU: VG0307
Professional Pricing
Add 9 more item(s) to unlock a 10% cart-wide discount!
Volume discounts are calculated on the total number of items in the cart across all references.
Compliance & Data Sheets
Selection verified by our biomedical team for compliance with clinical standards.
Clinical Description
Key Specifications
The Visiomed Inhaler is a paediatric valved holding chamber (spacer) in clear polycarbonate with two silicone valves, used to give metered-dose inhaler treatments to infants and young children. By slowing the particles and reducing their size, it promotes lung deposition while limiting deposition in the mouth and throat.
- Age ranges: 0 to 9 months or 9 months to 6 years, each with a suitable paediatric mask
- Chamber: clear polycarbonate, BPA-free, 320 ml volume
- Valves: 2 silicone valves, spare valve set included
- Mask: latex-free
- Inlet: universal adapter compatible with metered-dose inhalers
B2B Logistics
- 24h Delivery in Casablanca & Surroundings
- Morocco Shipping (48h-72h)
- Certified invoicing for clinical accounting
Buying Guide & Prices: Oxygen Concentrators & CPAP in Morocco
Read our complete buying guide
Procurement reassurance
Optimize your medical infrastructure with Inhaler spacer Visiomed by Visiomed (SKU: VG0307). This high-grade equipment is available with transparent pricing and original manufacturer support.
After checkout: PDF invoice, public tracking, and the client portal for history.
Frequently asked questions
What is the delivery time?
We deliver across Morocco within 24 to 48 hours for items in stock, directly from our hub in Casablanca.
Are the products certified?
All our products comply with international medical standards (CE, ISO) as required by Moroccan regulations.
Can individuals purchase from MediUnit?
MediUnit is a B2B platform exclusively for healthcare professionals, clinics, and medical organizations.
Tiered pricing for bulk orders
From 10 units: 198 MAD (excl. VAT)/unit (-10%). From 50 units: 176 MAD (excl. VAT)/unit (-20%).